The Wegovy 1mg pen and what it actually means for your treatment

The common misconception: 1mg is a 'low dose' you should rush through

A lot of people arrive at the 1mg wegovy pen with one thought: get past it quickly. The assumption is that lower steps are just formalities on the way to the 'real' treatment, and that rushing through them will mean faster results. That framing gets things backwards.

Each step in the semaglutide titration exists because the body needs time to adapt. Gastrointestinal side effects (nausea, loose stools, occasional vomiting) are most likely to appear after a dose change, and they tend to settle within a week or two once the body adjusts. Spending a full four weeks at the 1mg Wegovy step gives that adjustment time to happen. Cutting it short doesn't accelerate results; it increases the chance of side effects that might interrupt treatment altogether.

The NHS medicines guide for semaglutide is clear that the titration schedule is there for tolerability, not as a delay. That distinction is worth holding onto. A question our prescribers hear regularly is whether someone can skip a step, the honest answer is that it is a clinical decision, made with full knowledge of how someone has responded so far.

Worth checking: if you feel a step is going unusually fast or slow, that is exactly the kind of thing to raise with your prescribing team before changing anything.

Where the 1mg wegovy pen sits in the full schedule

Wegovy's licensed UK titration runs: 0.25mg (weeks 1–4), 0.5mg (weeks 5–8), 1mg (weeks 9–12), 1.7mg (weeks 13–16), and then 2.4mg as the standard maintenance dose. For those who tolerate it well and qualify, the recently approved 7.2mg maintenance dose extends the pathway further, you can read about Wegovy's full dose range and what the higher steps involve.

The 1mg pen itself follows the same format as every other Wegovy pen: a pre-filled, pre-set weekly injection. There is no dial to adjust, and if you want to understand exactly how the Wegovy pen dose is set and delivered, that is covered in full detail. Each pen contains four doses, so one pen covers roughly one calendar month at that step. If your order arrives on a Tuesday at the start of a pay period, or just before a bank holiday, the pen's four-dose structure means your schedule stays stable regardless.

Injection sites are the abdomen, thigh or upper arm, rotating each week to avoid local skin reactions. For full technique guidance, the step-by-step guide on using the Wegovy 1mg pen covers what to do before, during and after the injection. Storage follows the usual refrigerated 2–8°C requirement; always check the Patient Information Leaflet for the specific room-temperature window your pen allows if you need to travel.

If you want an overview of how the whole pen format works across doses, the four-dose pen structure is explained in more detail alongside the other steps.

Side effects at the 1mg step and when to act

The most commonly reported side effects at this stage are gastrointestinal: nausea, constipation, diarrhoea and indigestion feature in clinical data, with the 1mg step representing a meaningful increase from 0.5mg for some people. The STEP 1 trial, published in the New England Journal of Medicine, reported gastrointestinal symptoms as the most frequent adverse events across the titration period, with most cases described as mild to moderate and transient.

Most people find that any new symptoms at 1mg settle within one to two weeks. Eating smaller portions, avoiding very fatty meals, and staying well hydrated all help the adjustment period. These are practical steps, not cures, if symptoms are severe or persistent, contact your prescriber rather than adjusting your dose independently.

There are signs that need prompt medical attention rather than a wait-and-see approach. Severe stomach pain that extends toward the back, with or without vomiting, should be assessed urgently, it may indicate acute pancreatitis, which the MHRA highlighted in a 2026 Drug Safety Update for GLP-1 medicines. Equally, signs of serious allergic reaction or significant dehydration from prolonged vomiting or diarrhoea warrant same-day contact with a healthcare professional. You can also report any suspected side effects directly via the Yellow Card scheme.

For a broader look at how semaglutide works and the context behind the clinical evidence, the Wegovy treatment overview covers the mechanism, UK licence and trial results in one place. And if you are at the stage of thinking about whether private treatment might suit you, exploring your weight-loss treatment options is a sensible starting point before booking anything.